PMGC Holdings Inc.
PMGC Holdings Inc. (ELAB): 2 pipeline candidates · ~16 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
15.5 months
D/E 1.07 · 0% dilution
Lead: Phase 1
2 candidates
N/A
N/A
A transparent, data-derived signal for PMGC Holdings Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$6.5M
Cash
$14.4M
Quarterly Burn
$3.0M
Runway
15.5 mo
Revenue
$682K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
3
Total value held
$368K
| Holder | Shares | Value |
|---|---|---|
| jane street group, llc | 31,594 | $189K |
| morgan stanley | 15,000 | $90K |
| schonfeld strategic advisors llc | 14,800 | $89K |
Frequently asked questions
How many drug candidates are in PMGC Holdings Inc.'s pipeline?
PMGC Holdings Inc. (ELAB) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is PMGC Holdings Inc.'s lead drug candidate?
PMGC Holdings Inc.'s most advanced tracked candidate is el-22 (Phase 1) for Obesity (in combination with weight loss treatments to preserve muscle mass).
What is PMGC Holdings Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, PMGC Holdings Inc. has approximately 15.5 months of cash runway.
What is PMGC Holdings Inc.'s market capitalization?
PMGC Holdings Inc.'s market capitalization is approximately $6.5M.
Who is the CEO of PMGC Holdings Inc.?
Mr. Graydon Bensler C.F.A. is the chief executive officer of PMGC Holdings Inc. (ELAB).
Get the full picture on PMGC Holdings Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.